It is a record that nobody wants to hold: this month GlaxoSmithKline became the latest pharma entrant into the "billion dollar" fine club, and party to the largest ever health care fraud settlement in history. In a settlement with the Department of Justice first announced in November and finalized this month, the British health care giant agreed to pay $3 billion in fines to settle criminal and civil whistleblower claims, including...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In